Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
National Medical Care Company (4005.SR)
SAR106.50
-3.00 (-2.74%)
SA SAU Healthcare Medical - Care Facilities
Address
Al Imam Ahmad Ibn hanbal Street 11457
Riyadh, Riyadh Province, SA
Riyadh, Riyadh Province, SA
CEO
Abdulaziz Saleh Alobaid
Website
care.med.sa
IPO
2013-03-13
ISIN SA139051UIH0
Description
National Medical Care Company is dedicated to the comprehensive establishment, ownership, operation, and maintenance of healthcare facilities across the Kingdom of Saudi Arabia. Its substantial portfolio includes the 325-bed Riyadh Care Hospital, the 459-bed National Hospital, the Family Health Care Center, and the Care Company for Pharmaceutical and Medical Distribution. In addition to these institutional services, the company also provides home healthcare. Founded in 2003, it is headquartered in Riyadh, Saudi Arabia.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
SAR106.50
-3.00 (-2.74%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
183.1K
Beta
0.08
Float Shares
22.62M
Free Float %
50.6%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.81% | -9.47% | -24.34% | -36.70% | -36.86% | -29.64% | -36.13% | +2.45% | +59.11% | +68.94% | -17.70% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
106.50
DCF (Unlevered)
296.69
+178.6%
DCF (Levered)
351.84
+230.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
60% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 1 | -1 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
5.11
Safe zone
Piotroski F-Score
4 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+23.7% ★ Q1'26: +0.7% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+7.2% Q1'26: -38.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%-1.1% Q1'26: +16.2% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+23.3% ★ Q1'26: +16.2% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+16.8% ★
-
Share dilution Medical - Care Facilities: +0.0%-0.4% ★ Q1'26: -0.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.38× ★ Q1'26: 2.65× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 1 Rev. Ana. 2 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
878.67M
est: 874.80M (+0.4%)
|
900.65M
est: 932.87M (-3.5%)
|
855.08M
est: 828.13M (+3.3%)
|
763.80M
est: 780.54M (-2.1%)
|
708.39M
est: 698.44M (+1.4%)
|
808.95M
est: 806.00M (+0.4%)
|
845.38M
est: 851.05M (-0.7%)
|
917.93M
est: 914.57M (+0.4%)
|
1.08B
est: 1.17B (-7.6%)
|
1.29B
est: 1.32B (-1.7%)
|
1.60B
est: 1.61B (-0.5%)
|
1.72B
1.68B – 1.77B
+6.8% YoY
|
1.85B
1.80B – 1.94B
+7.8% YoY
|
2.08B
2.03B – 2.16B
+12.4% YoY
|
2.24B
2.18B – 2.33B
+7.5% YoY
|
2.38B
2.31B – 2.47B
+6.3% YoY
|
| EBITDA |
187.37M
est: 234.00M (-19.9%)
|
137.09M
est: 249.53M (-45.1%)
|
171.24M
est: 221.52M (-22.7%)
|
159.34M
est: 208.79M (-23.7%)
|
173.60M
est: 186.83M (-7.1%)
|
171.73M
est: 215.60M (-20.3%)
|
214.56M
est: 227.65M (-5.8%)
|
244.18M
est: 244.64M (-0.2%)
|
323.02M
est: 334.24M (-3.4%)
|
396.86M
est: 375.83M (+5.6%)
|
484.00M
est: 458.94M (+5.5%)
|
490.30M
478.93M – 505.65M
+6.8% YoY
|
528.77M
513.03M – 553.83M
+7.8% YoY
|
594.29M
578.47M – 617.88M
+12.4% YoY
|
638.69M
621.68M – 664.03M
+7.5% YoY
|
678.72M
660.65M – 705.65M
+6.3% YoY
|
| EBIT |
128.69M
est: 182.99M (-29.7%)
|
71.45M
est: 195.14M (-63.4%)
|
102.53M
est: 173.23M (-40.8%)
|
86.07M
est: 163.27M (-47.3%)
|
104.93M
est: 146.10M (-28.2%)
|
115.53M
est: 168.60M (-31.5%)
|
163.36M
est: 178.02M (-8.2%)
|
198.50M
est: 191.31M (+3.8%)
|
268.09M
est: 266.05M (+0.8%)
|
316.36M
est: 299.16M (+5.8%)
|
373.33M
est: 365.32M (+2.2%)
|
390.28M
381.22M – 402.50M
+6.8% YoY
|
420.90M
408.37M – 440.84M
+7.8% YoY
|
473.05M
460.46M – 491.83M
+12.4% YoY
|
508.39M
494.85M – 528.56M
+7.5% YoY
|
540.25M
525.87M – 561.69M
+6.3% YoY
|
| Net Income |
130.72M
est: 118.14M (+10.6%)
|
49.31M
est: 140.94M (-65.0%)
|
85.30M
est: 86.85M (-1.8%)
|
62.18M
est: 80.56M (-22.8%)
|
80.09M
est: 81.97M (-2.3%)
|
97.27M
est: 97.65M (-0.4%)
|
136.36M
est: 135.20M (+0.9%)
|
170.07M
est: 159.57M (+6.6%)
|
240.93M
est: 287.65M (-16.2%)
|
298.16M
est: 291.16M (+2.4%)
|
318.00M
est: 341.24M (-6.8%)
|
329.25M
322.05M – 336.44M
-3.5% YoY
|
393.30M
335.81M – 421.18M
+19.5% YoY
|
383.47M
370.20M – 403.25M
-2.5% YoY
|
430.84M
415.92M – 453.06M
+12.4% YoY
|
473.88M
457.47M – 498.32M
+10.0% YoY
|
| SGA |
76.28M
est: 39.97M (+90.8%)
|
127.32M
est: 42.63M (+198.7%)
|
105.44M
est: 37.84M (+178.6%)
|
16.30M
est: 35.67M (-54.3%)
|
15.32M
est: 31.91M (-52.0%)
|
59.26M
est: 36.83M (+60.9%)
|
30.97M
est: 38.89M (-20.3%)
|
26.31M
est: 41.79M (-37.0%)
|
49.91M
est: 45.57M (+9.5%)
|
56.62M
est: 51.24M (+10.5%)
|
63.13M
est: 62.58M (+0.9%)
|
66.85M
65.30M – 68.95M
+6.8% YoY
|
72.10M
69.95M – 75.51M
+7.8% YoY
|
81.03M
78.87M – 84.25M
+12.4% YoY
|
87.08M
84.77M – 90.54M
+7.5% YoY
|
92.54M
90.08M – 96.22M
+6.3% YoY
|
| EPS |
2.91
est: 2.64 (+10.3%)
|
1.12
est: 3.15 (-64.4%)
|
1.90
est: 1.94 (-2.1%)
|
1.39
est: 1.80 (-22.8%)
|
1.79
est: 1.83 (-2.2%)
|
2.17
est: 2.18 (-0.5%)
|
3.04
est: 3.02 (+0.7%)
|
3.79
est: 3.59 (+5.7%)
|
5.37
est: 6.42 (-16.3%)
|
6.65
est: 6.47 (+2.7%)
|
7.13
est: 7.62 (-6.5%)
|
7.44
7.22 – 7.54
-2.5% YoY
|
8.07
7.53 – 9.44
+8.6% YoY
|
8.60
8.30 – 9.04
+6.5% YoY
|
9.66
9.33 – 10.16
+12.4% YoY
|
10.63
10.26 – 11.17
+10.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-10 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-05 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-03 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-26 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
240.59M
OE per share TTM
5.39
Owner's Yield
5.20%
Maintenance CapEx ratio
55.35%
Maint CapEx / Avg PPE
72.2%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 46 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares MSCI Saudi Arabia ETF KSA | 0.22% | 1.44M | 0.75% |
| 2 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.04% | 149.5K | 0.72% |
| 3 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.04% | 239.2K | 0.55% |
| 4 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.04% | 128.1K | 0.74% |
| 5 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.01% | 2.02M | 0.06% |
| 6 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.01% | 1.08M | 0.39% |
| 7 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.01% | 33.4K | 0.56% |
| 8 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.01% | 56.6K | 0.44% |
| 9 | State Street SPDR Morningstar Multi-Asset Global Infrastructure UCITS ETF (Dist) MAGI.L | 0.01% | 87.1K | 0.40% |
| 10 | FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE | 0.01% | 22.9K | 0.58% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
172.4K
Shares Outstanding
44.69M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Abdulaziz Saleh Alobaid | Chief Executive Officer & MD | 397.6K | — |
| Bader bin Sager Alotaibi | Chief Medical Officer-EMHA | 212.0K | — |
| Jahanzeb Ahmed Khan | Chief Financial Officer | — | male |
| Mohammed Abdulrahman Algesayer | Chief Human Resources Officer | — | — |
| Nasser Saleh Alluhaidan | Chief Operating Officer | — | male |
| Ibrahim Abdullah Al-Ammar | Chief Information Technology Officer | — | — |
| Adel Attallah AlJabrti | Board Secretary | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4005.SR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
